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 The high frequency of glucose-6-phosphate dehydrogenase (G6PD) deficiency gene in malaria endemic regions is 
believed to be due to the enzyme deficiency advantage against fatal malaria. However, the mechanism of this protection is not well 
understood and therefore was investigated by comparing differences in plasmodial parasitaemia, full blood count profile and the 
severity of clinical malarial symptoms of G6PD deficient and G6PD non–deficient cohort groups in the population. Our results 
showed that 10.4% (63/606) of those tested carried the G6PD deficiency gene. G6PD deficient heterozygous females and 
hemizygous males manifested significantly reduced (P<0.05) parasitaemia, less severe malarial anaemia, less severe clinical 
malarial symptoms and elevated haematological profile during the progress of malaria when compared with G6PD non–deficient 
subjects. The results seem to suggest that G6PD deficiency gene could be among the factors that confer malaria protection in the 
hosts through reduction of severe malarial anaemia, density parasitaemia and clinical malarial symptoms while having less effect 
on frequency of infection perse. 
 




 Malaria is caused by the mosquito–borne 
haematoprotozoan parasite of the genus Plasmodium and 
transmitted by the female anopheles mosquito. It is a severe 
public health problem in tropical areas and a vast majority of 
mortality and morbidity is caused by infection with P. 
falciparum. At least 90% of the deaths occur in Sub-Saharan 
Africa (Tsuji et al., 2001;   Greenwood & Mutabingwa, 2002). 
Between 300 – 500 million clinical cases are reported each 
year and an estimated yearly mortality rate of over one million 
deaths (Felger et al., 2003).  
 Glucose-6-phosphate dehydrogenase (G6PD) 
deficiency is one of the most common inherited single gene 
disorders in the world (Kar et al., 1990). G6PD, a key enzyme 
in the pentose phosphate pathway (PPP), catalyses the 
production of reduced nicotinamide-adenine dinucleotide 
phosphate (NADPH) within the erythrocytes. This reduced 
cofactor is used to regenerate reduced glutathione (GSH), to 
maintain a reduced environment within the red cell, to enhance 
the ability of the cell to withstand haemolysis that could result 
from oxidative damage, characteristic of or following exposure 
to oxidant drugs (Lui et al., 1994, Cheesbrough, 2000). The 
protection against malaria severity conferred by G6PD 
deficiency in malaria endemic regions of the world has been 
widely speculated. However, the mechanism by which the 
G6PD deficiency gene conveys resistance to malaria is not 
properly understood. Resistance to malaria by G6PD deficient 
individuals is thought to be due to increased oxidative stress in 
G6PD deficient cells, hence, red cell/parasite damage (Lui et 
al., 1994). Although protection against malarial mortality has 
been indirectly estimated using gene frequencies, the degree 
of protection has not been determined using cohort studies. In 
this study, therefore, the current incidence of G6PD deficiency 
and its protective effect on malaria, were investigated in 
Bamenda population of Cameroon with intent to throw more 
light into the role this factor could play in the protection against 
malaria. 
 
MATERIALS AND METHODS 
 
Study area: Cameroon, a malaria endemic central African  
 
country has high malaria infection rates all-year-round 
throughout the country. Bamenda is in the North Western part 
of the country and incorporates about 2% of Cameroon’s total 
population. The populace has very low knowledge of G6PD 
deficiency.  
 
Subjects and blood sample collection: A total of 606 
volunteers aged between 3 to 70 years, who sought for 
malaria treatment at the Bamenda Provincial Hospital and 
other volunteers in the community participated in the study. 
Blood samples (5ml) were collected by venipuncture into 
sample tubes containing EDTA as anticoagulant and then 
rocked gently to mix the blood and the anti-coagulant. 
However, blood samples (0.1ml) for routine monthly malaria 
test were collected by thumb pricking using lancets. Volunteer 
cohort groups, comprising forty (40) G6PD deficient and 40 
G6PD non-deficient dominant homozygotes (HbAA) were 
selected from those tested and monthly monitored for the 
frequency of plasmodial infection, haemoglobin concentration, 
parasite density, percentage parasitaemia, blood sugar level, 
and other clinical malaria presentations such as respiratory 
distress, high fever, severe headache, diarrhoea, vomiting, 
weakness and anaemia for a period of one year, whenever 
they show signs of malaria infection. Selection was based on 
the individual’s accessibility and willingness to take part in 
monitoring for the plasmodial infection. 
 
Malaria diagnosis: Malaria was diagnosed based on clinical 
presentations of malaria symptoms and confirmed by 
microscopic examination of Giemsa or Leishman stained thick 
and thin blood films for malaria parasite.  
 
Parasitaemia and parasite density determinations: 
Parasitaemia was microscopically determined from the total 
number of infected and uninfected RBCs counted in 1000 
RBCs in a thin film (oil immersion, X100), using a hand tally 
counter according to the method of Greenwood & Armstrong, 
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% Parasitaemia =            Total number of infected RBCs                x  100 
                   Total number of RBCs (infected and uninfected) 
 
 Parasite density was estimated by counting the number of intra-erythrocytic parasites in 10,000 RBCs (approximately 36-
45 oil immersion microscopic fields) (Greenwood & Armstrong, 1991). The parasite density per μl was then calculated as follows: 
 
Parasite density(/μl)    =   RBC count (/μl)   x   Number of parasites per 10,000 RBCs 
                                    10,000 
 
Glucose oxidase reagent for fasting blood sugar (phenol 
free): The glucose reagent (Teco Diagnostic) was 
reconstituted by mixing 50ml of distilled water with each bottle 
of reagent. The reconstituted reagent contained 15μl/ml 
glucose oxidase, 1.2μl/ml Peroxidase (horseradish), 4.0 μl/ml 
mutarotase, 0.38mM 4–minoantipyrine, 10mM p– 
hyroxybenzene sulfonate and non-reactive ingredients. The 
reagent was stored at 2 – 8oC in amber containers. 
 
Clinical symptoms in the cohort group during malaria 
infection: The cohort groups were observed for clinical 
symptoms during malaria infection by the medical doctors in 
the hospital in the area of study. The intensity and severity of 
the symptoms were rated from 1 to 5 (+ to +++++) in the 
increasing order of severity. 0 means that the symptom was 
not observed. 
 
Determination of G6PD deficiency: The activity of G6PD 
was qualitatively determined by fluorescent spot test as 
described by Beutler et al. (1996). The reaction mixture 
contained glucose-6-phosplate (0.01M), NADP+ (0.01M), 
saponins (0.02M), phosphate buffer, pH 7.4 and distilled water. 
Fluorescence was produced due to the reduction of NADP+ to 
NADPH. This reaction is coupled to oxidation of glucose-6-
phosphate to 6-phosphogluconolactone and catalysed by 
G6PD. Specimen with G6PD activity of <20% of normal 
(severe deficiency) do not fluoresce as the small amount of 
NADPH formed is reoxidised by glutathione present in the 
reagent. Presence of fluorescence indicated normal cells while 
weak fluorescence indicated slight deficiency.  
 
Full blood count: Haematological indices [erythrocyte counts, 
white blood cell count (WBC), mean cell volume (MCV), mean 
cell haemoglobin (MCH), mean cell haemoglobin concentration 
(MCHC), packed cell volume (PCV) or haematocrit (HCT), Hb 
concentration and platelet count (PLT)] were analysed using 
an automated system, CELL-DYN 1200 Hematology Analyser 
(Abbott, USA). 
 
Determination of serum fasting blood sugar: Glucose (1.5 
ml), reconstituted reagent was pipetted into clean cuvettes 
labeled blank, standard and tests and incubated for 5 minutes 
at 37oC. Then 10μl of standard and test sera were added to 
the respective cuvettes and incubated for another 10 minutes. 
The amount of coloured complex formed was proportional to 
glucose concentration and can be photometrically measured at 
the wavelength of 520nm against the reagent blank. The 
glucose concentration in the subject’s serum was then 
calculated using the formula: 
 
Fasting Blood Sugar = Absorbance of Standard     x   Conc. of Standard (mg/dl) 
                              Absorbance of Test 
  
Haemoglobin (Hb) genotype: Haemoglobin genotypes were 
determined by cellulose acetate membrane electrophoresis 




Prevalence of G6PD deficiency in Bamenda population: 
The result of the G6PD status in the Bamenda population 
(Table 1a & 1b) suggest that the prevalence of the enzyme 
deficiency in males (9.2%) is significantly higher (P<0.05) than 
that in females (1.2%) resulting in  a 10.4% prevalence of the 
enzyme deficiency in the population. 
 
Table 1a: G6PD Activity 
Observation No of Subjects 
Fluorescence (Normal Activity) 89.6% (543/606) 
Weak Fluorescence (Low Activity) 4.45% (27/606) 
No Fluorescence (Severe 
Deficiency) 
5.95%  (36/606) 
Table 1b: G6PD deficiency in male and female population in 
Bamenda 
Sex G6PD deficiency prevalence (%) 
Male 9.2 (56/606) 
Females 1.2 (7/606) 
Total 10.40 (63/606) 
 
 Clinical symptoms during malaria infection in the 
cohort groups: The results of clinical symptoms during malaria 
infection (Table 2a) reveal that a greater number of G6PD 
non–deficient subjects suffered more frequent and more 
severe malaria attack while G6PD deficient subjects had 
significantly fewer episodes of severe malarial anaemia, few 
episodes of high parasitaemia and less severe clinical 
symptoms. Although the average fasting blood sugar of G6PD 
non-deficient subjects was lower than that of G6PD deficient 
subjects, the difference was not statistically significant 
(P>0.05) (Table 2b). 
 
Table 2a:  Protective effect of sickle and G6PD deficiency genes against malaria morbidity 
Clinical malarial symptoms G6PD non-deficient subjects 
(n = 40) 
 G6PD deficient 
(n = 40) 
 No of cases observed in the cohort groups 
Severe malarial anaemia episodes 
(Hb<6g/dl and >10,000 Parasitaemia) 
5  - 
All cause severe anaemia episodes 
(Hb<6g/dl and any level parasitaemia) 
6  2 
High density parasitaemia episodes 
(>10,000 Parasitaemia) 
5  - 
Cerebral malaria episodes 3  - 
Hypoglycaemic episodes 7  3 
Coma 1  - 
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Seizure 2  - 
Respiratory distress 2  1 
Severe headache 10  5 
Diarrhea  8  3 
Severe vomiting  6  2 
Av. frequency of malaria attack 4  1 
 
Table 2b: Average fasting blood sugar concentration in malaria subjects 
 G6PD non-deficient  
(n = 40) 
 
G6PD deficient  
(n = 40) 
Fasting blood sugar  66.5 ± 13.6 75.3 ± 24.4 
Note: Normal value (70 – 105mg/dl) 
 
Annual frequency of malaria attack in different G6PD 
status: As per the data extracted from the questionnaires and 
hospital files, the frequency of malaria attack in different G6PD 
deficient and non-deficient subjects is presented in table 3. 
The results seem to indicate that the frequency of malaria 
attack is more in G6PD non-deficient subjects than in G6PD 
deficient ones. 
 
Table 3:  Annual frequency of malaria attack of G6PD deficient and non–deficient individuals 
 Annual frequency of malaria attack 
 ≤ 2x 2 – 5x ≥ 5x Total 
 No % No % No % No % 
G6PD deficient 42 66.7 11 17.5 10 15.9 63 100 
G6PD non-deficient 133 24.5 245 45.1 165 30.4 542 100 
 
 Haematological profile and parasitaemia in 
plasmodial infected G6PD deficient and non-deficient subjects: 
Data in table 4 shows that G6PD deficient subjects suffered 
less malaria attacks, had significantly (P<0.05) lower parasite 
densities and percentage parasitaemia but significantly higher 
(P<0.05) Hb concentration, RBC, PCV, MCV, MCH and 
platelet count and lower WBC and RDW though not 
statistically significant (P>0.05) than in non-deficient 
individuals.  
 
Table 4: Haematological profile and parasitaemia in malaria infected subjects with or without G6PD deficiency 
Haematological variable / Parasitaemia G6PD non-deficient subjects 
(n = 40) 
G6PD deficient subjects 
(n = 40) 
 
Hb (g/dl) 9.6 ± 2.1 11.7 ± 1.04  * 
PCV (%) 22.5 ± 4.6 26.9 ± 2.5  * 
RBC (M/μl) 3.2 ± 0.7 3.6 ± 0.4  * 
MCV (fl) 72.2 ± 8.4 74.5 ± 7.1  * 
MCH (pg) 30.9 ± 4.1 32.4 ± 3.2  * 
MCHC (g/dl) 42.8 ± 2.3 43.5 ± 1.6 φ 
Platelets (K/μl) 258.7 ± 119.7 270.8 ± 88.8  * 
WBC (K/μL) 7.5 ± 4.9 7.1 ± 3.2  * 
RDW (%) 14.8 ± 3.3 13.5 ± 2.4 φ 
Parasite density (No/μl) 1291 ± 259.2 775.3 ± 158.7  * 
% Parasitaemia 0.4 ± 0.1 0.2 ± 0.08 * 
Annual frequency (No of times) 2 – 4 < 2  * 
    Note: Data is presented as: Mean ± Standard deviation   
   * = Significant (P<0.05)   φ = Not Significant (P>0.05) 
 
Severity of malaria attack in G6PD–deficient and non-deficient subjects: Severity increased as the haemoglobin concentration 
decreased while parasite density increased (Table 5). 
 
Table 5: Hb concentration and parasitaemia in cohort groups during malaria attack 
Hb (g/dl) Severity G6PD non-deficient 
(n = 40) 
G6PD deficient  
(n = 40) 
  No of cases observed 
< 6 ++++ 7 1 
6 – 8  +++ 8 5 
8 – 10 ++ 12 14 
10 – 12  + 13 20 
 
Parasite Density  
(No/μl) 
Severity G6PD non-deficient 
(n = 40) 
G6PD deficient  
(n = 40) 
  No of cases observed 
> 10000 +++++ 3 - 
8000 – 10000  ++++ 9 - 
6000 – 8000  +++ 10 1 
4000 – 6000  ++ 9 5 
2000 – 4000  + 9 1 
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DISCUSSION 
 The high frequency of G6PD deficiency gene in 
malaria endemic populations of tropics and sub-tropics could 
be due to the enzyme deficiency gene advantage against fatal 
malaria (Aruoma, 1993). The possible protective mechanism of 
this protection was investigated in the population of Bamenda 
district of Cameroon which was earlier revealed to have 
malaria prevalence of 42.2%, most of the plasmodial infection 
(93.7%) being caused by Plasmodium falciparum (Awah & 
Uzoegwu, 2007). The 10.4% incidence of G6PD deficiency 
gene screened for this population during this study is similar to 
most of the incidences reported for most of the malaria 
endemic areas of the world (El-Hazmi & Warsy, 1994; Allison, 
2004). Our major observation in this study that G6PD non-
deficient individuals were more vulnerable to malaria disease 
and subsequently exhibited more severe malarial anaemia and 
symptoms, higher parasite density, more frequency of 
plasmodial attack and lower Hb concentration during 
plasmodial infection than the enzyme deficient cohorts seem to 
support the hypothesis that this enzyme deficiency might have 
arisen in a bid to fight against falciparum malaria (Kar et al., 
1990). Because severe anaemia could be provoked by 
malnutrition and iron deficiency usually associated with the 
people of the developing countries of Africa, only those who 
were adjudged to be nutritionally balanced and at balanced 
diets, at least for the period of the study were selected for the 
study. It is noteworthy that severe drug-induced haemolysis 
and rhabdomyolysis were not observed in this study, perhaps 
due to the fact that only quinine sulphate (200mg) and not 
chloroquine sulphate or other anti-malarial drugs were used as 
the main anti-malarial drugs in this area of study. Furthermore, 
the haemolysis observed in G6PD deficiency could not have 
been food-induced since fava beans or any other dietary 
factors that could induce haemolysis in G6PD deficient 
individual are not known to be consumed in Bamenda. G6PD 
deficiency defect is known to be harmless unless red cells are 
challenged by primaquine, dietary factors such as fava beans 
or parasite infections such as malaria. Plasmodial infection is 
likely to induce oxidative stress to the erythrocyte membrane 
(Aruoma, 1993). It is therefore likely that the differences in 
haematological indices, percentage parasitaemia and parasite 
densities of the G6PD deficient and non–deficient cohorts 
could have been as a result of plasmodial infection. Decreased 
parasitaemia as observed in G6PD deficient group in this 
study is consistent with similar observation reported by Allison 
and Clyde (1961). Based on the aforementioned observations, 
it is reasonable therefore, to adduce that malaria parasites 
could grow better in the RBCs of G6PD non-deficient 
individuals than in the RBCs of the G6PD deficient ones, which 
could result to the high parasite density observed in non–
deficient subjects. Our result, therefore, favours the malaria / 
G6PD deficiency hypothesis, which affirmed that G6PD 
deficiency, are contributing factors to malarial resistance 
(Usanga & Luzzatto, 1985). The result is also supported by the 
observation that more cohort G6PD non-deficient subjects, 
particularly children below 5 years of age were admitted in the 
hospital for the treatment of severe malaria than cohort G6PD 
deficient subjects during which severe malaria associated with 
symptoms including cerebral malaria, seizure, severe 
headache, vomiting, diarrhoea and respiratory distress, were 
evident. Furthermore, more episodes of severe malarial 
anaemia (Hb <6g/dl), hypoglycaemia, and high parasitaemia 
(>10000parasites/μl) were more evident in well nourished 
G6PD non-deficient subjects compared to G6PD deficient 
ones. Our results also revealed lower morbidity and mortality 
rates caused by P. falciparum since both factors are related to 
Hb concentration and parasite densities in malaria infection 
(Field, 1949). However, since severe malaria may occur in the 
face of occult malaria infection when the parasites are 
sequestered and their growth cycle is tightly synchronized, the 
use of parasitaemia may be an unreliable guide to malaria 
severity. The  existence  of  more  severe anaemic episodes in  
 
children below 5 years old could be due to the more 
susceptibility of their red blood cells to haemolysis and is 
consistent with the observation of Snow et al. (1997). 
Hypoglycaemic episodes, most common in children with 
severe malaria (Molyneux et al., 1989) were revealed to be 
more common in G6PD non-deficient malaria infected children 
than in G6PD deficient ones; possibly due to increased 
consumption of glucose in the peripheral tissues by the 
parasites (Dekker et al., 1997). Furthermore, more malaria–
derived products and/or quinine could directly or indirectly 
stimulate the β-cells of the pancreatic Islets, leading to 
hyperinsulinaemia and consequently hypoglycaemia in adults 
subjects as observed in this study.  From the results of this 
study, it is likely that G6PD deficiency gene inheritance confers 
some protection against severe malaria attack by reducing 
parasite density and consequently reducing debilitating 
symptoms. But the mechanism is not still clear and is presently 
being investigated. To understand clearly, the protective role of 
G6PD deficiency gene during the progress of malaria, it is 
suggested that, the mechanism of intravascular haemolysis of 
both parasitised and unparasitised red blood cells in malarial 
attack should be elucidated and also the detrimental effects of 
G6PD deficiency gene in the proliferation of P. falciparum 
investigated at the molecular level. 
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